Living Healthy

woman measuring glucose test level check with blood on finger by

GLP-1 Explained and Hypoglycemic Effects

GLP-1 (Glucagon-Like Peptide-1) is an incretin hormone produced in the small intestine after meals. GLP-1 plays an important role in regulating blood sugar levels through various mechanisms. Here are the ways that GLP-1 helps lower blood sugar:

1. Stimulates insulin secretion:

  • Mechanism: GLP-1 stimulates beta cells in the pancreas to release insulin when blood glucose levels rise after eating.
  • Effects: Insulin helps cells in the body (especially muscle cells and fat cells) absorb glucose from the blood, lowering blood sugar levels.

2. Inhibits glucagon secretion:

  • Mechanism: GLP-1 inhibits alpha cells in the pancreas that secrete glucagon. Glucagon is a hormone that raises blood sugar by stimulating the liver to release stored glucose into the bloodstream.
  • Impact: Reduces glucagon secretion to help prevent hyperglycemia after meals.

3. Slow down the process of stomach emptying:

  • Mechanism: GLP-1 slows down the movement of food from the stomach to the small intestine.
  • Impact: This slows down the absorption of glucose into the bloodstream, helping to prevent a sudden increase in blood sugar after meals.

4. Create a feeling of fullness:

  • Mechanism: GLP-1 acts on the brain, creating a feeling of fullness and reducing appetite.
  • Impact: Helps control food intake, thereby controlling the amount of glucose absorbed into the bloodstream.

5. Increased Insulin Sensitivity:

  • Mechanism: GLP-1 can improve the sensitivity of cells to insulin.
  • Impact: Helps insulin work more efficiently in carrying glucose from the blood into cells, reducing blood glucose levels.

Comprehensive Impact:

Together, these mechanisms make GLP-1 an important hormone in maintaining blood sugar balance after meals. In patients with type 2 diabetes, GLP-1 or GLP-1 agonists (GLP-1 agonists) are often used to improve insulin resistance and control blood glucose. They have been shown to be very effective in lowering HOMA-IR and improving cholesterol rates, as seen in clinical studies.

GLP-1 helps reduce blood sugar through many mechanisms such as stimulating insulin secretion, inhibiting glucagon secretion, slowing down stomach emptying, creating a feeling of fullness, and increasing insulin sensitivity. These effects make GLP-1 an important tool in the treatment and management of type 2 diabetes and blood glucose-related disorders.

Could a decrease in HOMA-IR be associated with an increase in GLP-1?

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) and GLP-1 (Glucagon-Like Peptide-1) are both involved in blood glucose regulation and insulin resistance. Here is the association between a decrease in HOMA-IR and an increase in GLP-1:

1. HOMA-IR and Insulin Resistance:

  • Insulin Resistance: The HOMA-IR is an indicator that assesses the body’s level of insulin resistance. A high HOMA-IR indicates that the body is not using insulin effectively to regulate blood glucose levels.
  • Reduced HOMA-IR: When the HOMA-IR index decreases, this indicates that insulin resistance has improved, which means that insulin in the body is more efficient.

2. GLP-1 and Blood Glucose Regulation:

  • Function of GLP-1: GLP-1 stimulates insulin secretion from the pancreas, inhibits glucagon secretion, slows down stomach emptying, and creates a feeling of fullness. All of these mechanisms help lower blood sugar.
  • Effects of GLP-1: Increasing GLP-1 levels can improve blood glucose regulation and enhance insulin efficacy, which in turn may reduce insulin resistance.

3. Association between HOMA-IR Reduction and GLP-1 Increase:

  • Increased GLP-1 Reduces Insulin Resistance: Many studies have shown that increasing GLP-1 through the use of GLP-1 agonists (GLP-1 agonists) can reduce insulin resistance and improve HOMA-IR. This means that increasing GLP-1 helps insulin work more efficiently, thereby reducing HOMA-IR.
  • Indirect Effects: When GLP-1 increases, it helps the body better control blood glucose, reduces pressure on the pancreas to produce insulin, and reduces insulin resistance. Therefore, it can be said that part of the impact of the decrease in HOMA-IR is related to the increase in GLP-1.


Decreased HOMA-IR may be associated with an increase in GLP-1, because GLP-1 improves insulin efficacy and reduces insulin resistance. Increasing GLP-1 through natural methods or the use of GLP-1 agonists may contribute to a reduction in HOMA-IR, improve glycemic control, and aid in the treatment of conditions related to insulin resistance. Thus, it can be said that a decrease in HOMA-IR may be an indirect effect of increased GLP-1 in the body.

Introducing Collagen GlucoTrojan from JBA Brands

Collagen GlucoTrojan from JBA Brands is the perfect combination of collagen peptides and natural essences, providing outstanding benefits to your health and skin. With its high collagen content and precious ingredients from nature, this product not only helps maintain youthfulness but also supports overall health. The product is manufactured in the US and has been listed on the FDA’s Daily Med page.

Clinical Study Results:

  • Passed 2 Clinical Trials: The product has undergone 2 clinical trials in the US.
  • Reduced HOMA-IR: Clinically proven to reduce HOMA-IR (insulin resistance index) by 42% within 4 weeks, which means the product helps increase the secretion of the hormone GLP-1 in the intestines.

Improved Cholesterol Ratio: LDL/HDL ratio decreased by 67% and TC/HDL ratio decreased by 67%, significantly improving heart health.

Leave your comment

Your email address will not be published. Required fields are marked *

Translate »